Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Shire

Status and phase: Completed; Phase 4

Conditions: Kidney Failure, Chronic

Treatments: Drug: Lanthanum carbonate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00160121

SPD405-401

Details and patient eligibility

About

The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with ESRD who currently require treatment for hyperphosphatemia

Exclusion criteria

• Female patient who is pregnant or lactating
• Patient has used any investigational product within 30 days of screening

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)